Metabolomic effects of androgen deprivation therapy treatment for prostate cancer

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer

Abstract Androgen deprivation therapy (ADT) is the main treatment strategy for men with metastatic prostate cancer (PC). However, ADT is associated with various metabolic disturbances, including impaired glucose tolerance, insulin resistance and weight gain, increasing risk of diabetes and cardiovas...

Full description

Bibliographic Details
Main Authors: Jen‐Tsan Chi, Pao‐Hwa Lin, Vladimir Tolstikov, Taofik Oyekunle, Emily Y. Chen, Valerie Bussberg, Bennett Greenwood, Rangaprasad Sarangarajan, Niven R. Narain, Michael A. Kiebish, Stephen J. Freedland
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:Cancer Medicine
Subjects:
3‐hydroxybutyric acid
3‐formyl indole
ADT
androgen sulfate
indole‐3‐carboxaldehyde
ketogenesis
Online Access:https://doi.org/10.1002/cam4.3016

Internet

https://doi.org/10.1002/cam4.3016

Similar Items